Skip to main content
Log in

Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The molecular mechanisms responsible for behavior are largely unknown. A state of the art model, paving the path from genes to behavior, is offered by transgenic animals. Candidate molecules are classic neuropeptides, such as vasoactive intestinal peptide (VIP). Transgenic mice harboring a chimeric VIP gene driven by the polyoma promoter were produced. Behavioral studies revealed learning impairment and prolonged retardation in memory acquisition in the genetically altered animals. Furthermore, reduced performance was observed when the male transgenic mice were tested for sexual activity in the presence of receptive females. Surprisingly, radioimmunoassays showed an approx 20% decrease in the VIP content of the transgenic mice brains. To directly assess genetically reduced VIP content as a cause for learning impairment, transgenic mice carrying diphtheria toxia-encoding sequences driven by the rat VIP promoter were created. These animals had reduced brain VIP and exhibited deficiencies in learning abilities, strongly supporting an important neurobiological function for VIP in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agoston D. V., Eiden L. E., Brenneman D. E., and Gozes I. (1991) Spontaneous electrical activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cell cultures.Mol. Brain Res. 10, 235–240.

    Article  PubMed  CAS  Google Scholar 

  • Arimura A. (1992) Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research.Regulatory Peptides 37, 287.

    PubMed  CAS  Google Scholar 

  • Bodner M., Fridkin M., and Gozes I. (1985) VIP and PHM-27 sequences are located on two adjacent exons in the human genome.Proc. Natl. Acad. Sci. USA 82, 3548–3551.

    Article  PubMed  CAS  Google Scholar 

  • Bohnlein E., Chowdhury K., and Gruss P. (1985) Functional analysis of the regulatory region of polyoma mutant F9-1 DNA.Nucleic Acids Res. 13, 4789–4809.

    Article  PubMed  CAS  Google Scholar 

  • Brenneman D. E. and Eiden L. E. (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival.Proc. Natl. Acad. Sci. USA 83, 1159–1162.

    Article  PubMed  CAS  Google Scholar 

  • Brenneman D. E., Nicol T., Warren D., and Bowers L. M. (1990) Vasoactive intestinal peptide: a neurotrophic releasing agent and astroglia mitogen.J. Neurosci. Res. 25, 386–394.

    Article  PubMed  CAS  Google Scholar 

  • Csillag A., Zilles K., Schleicher A., and Hajos F. (1992) Matching localization of immunoreactive VIP and VIP receptor in the visual cortex.Neurosci. Soc. Abs. 18, 1451.

    Google Scholar 

  • Dixson A. F., Kendrick K. M., Blank M. A., and Bloom S. R. (1984) Effects of tactile and electrical stimuli upon the release of vasoactive intestinal polypeptide in the mammalian penis.J. Endocrinol. 100, 249–252.

    Article  PubMed  CAS  Google Scholar 

  • Emson P. C., Fahrenkrug J., Schaffalitzky de Muckadell O. B., Jessel T. M., and Iverson, L. L. (1978) Vasoactive intestinal peptide (VIP) vesicular localization and potassium evoked release from rat hypothalamus.Brain Res. 143, 174–178.

    Article  PubMed  CAS  Google Scholar 

  • Fink J. S., Verhave M., Walton K., Mandel G., and Goodman R. H. (1991) Cyclic-AMP and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene.J. Biol. Chem. 266, 3882–3887.

    PubMed  CAS  Google Scholar 

  • Giladi E., Shani Y., and Gozes I. (1990) The complete structure of the rat VIP gene.Mol. Brain Res. 7, 261–267.

    Article  PubMed  CAS  Google Scholar 

  • Glowa J. R., Panlilio L. V., Brenneman D. E., Gozes I., Fridkin M., and Hill J. M. (1992) Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist.Brain Res. 570, 49–53.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., Bodner M., Shani Y., and Fridkin M. (1986) Structure and expression of the vasoactive intestinal peptide (VIP) gene in a human tumor.Peptides 7, 1–6.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I. and Brenneman D. E. (1989) VIP molecular biology and neurobiological function.Mol. Neurobiol. 3, 1–36.

    Article  Google Scholar 

  • Gozes I. and Brenneman D. E. (1993) Neuropeptides as growth and differentiation factors in general and VIP in particular.J. Mol. Neurosci. 4, 1–9.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I. and Fridkin M. (1992) A fatty neuropeptide: potential drug for noninvasive impotence treatment in a rat model.J. Clin. Invest. 90, 810–814.

    PubMed  CAS  Google Scholar 

  • Gozes I., Hill J. M., Mervis R. F., Fridkin M., and Brenneman D. E. (1990) VIP antagonist produces neuronal damage and retardation of behavioral development in neonatal rats.Neurosci. Soc. Abs. 16, 1292.

    Google Scholar 

  • Gozes I., Meltzer E., Rubinraut S., Brenneman D. E., and Fridkin M. (1989) Vasoactive intestinal peptide potentiate sexual behavior: inhibition by novel antagonist.Endocrinology 125, 2945–2949.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., McCune S. K., Jacobson L., Warren D., Moody T. W., Fridkin M., and Brenneman D. E. (1991a) An antagonist to vasoactive intestinal peptide: effects on cellular functions in the central nervous system.J. Pharmacol. Exp. Therap. 257, 959–966.

    CAS  Google Scholar 

  • Gozes Y., Brenneman D. E., Fridkin M., Asofsky R., and Gozes I. (1991b) A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytesBrain Res. 540, 319–321.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., Shani Y., and Rostene W. H. (1987) Developmental expression of the VIP-gene in brain and intestine.Mol. Brain Res. 2, 137–148.

    Article  CAS  Google Scholar 

  • Griep A. E. and Westphal H. (1990) Differentiation versus proliferation of transgenic mouse lens cells expressing polyoma large T antigen: evidence for regulation by an endogenous growth factor.New Biol. 2, 727–738.

    PubMed  CAS  Google Scholar 

  • Heinrich G., Gros P., and Habener J. F. (1984) Glucagon gene sequence.J. Biol. Chem.,259, 14,082–14,087.

    CAS  Google Scholar 

  • Hill J. M., Gozes I., Hill J. L., Fridkin M., and Brenneman D. E. (1991) Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat.Peptides 12, 187–192.

    Article  PubMed  CAS  Google Scholar 

  • Lamperti E. D., Rosen K. M., and Villa-Komaroff L. (1991) Characterization of the gene and messages for vasoactive intestinal polypeptide (VIP) in rat and mouse.Molecular Brain Res. 9, 217–231.

    Article  CAS  Google Scholar 

  • Loren I., Emson P. C., Fahrenkrug J., Bjorklund A., Alumets J., Hakanson R., and Sundler F. (1979) Distribution of vasoactive intestinal polypeptide in the rat mouse brain.Neuroscience 4, 1953–1976.

    Article  PubMed  CAS  Google Scholar 

  • Magistretti P. J., Morrison J. H., Shoemaker W. J., Sapin V., and Bloom F. E. (1981) Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism.Proc. Natl. Acad. Sci. USA 78, 6535–6539.

    Article  PubMed  CAS  Google Scholar 

  • Mahon K. A., Chepelinsky A. B., Khillan J. S., Overbeek P. A., Piatigorsky J., and Westphal H. (1987) Oncogenesis of the lens in transgenic mice.Science 235, 1622–1628.

    Article  PubMed  CAS  Google Scholar 

  • Maxwell I. H., Maxwell F., and Glode L. M. (1986) Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: possible strategy for inducing cancer cell suicide.Cancer Res. 46, 4660–4664.

    PubMed  CAS  Google Scholar 

  • Maxwell F., Maxwell I. H., and Glode L. M. (1987) Cloning, sequence determination and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain.Molec. Cell. Biol. 7, 1576–1579.

    PubMed  CAS  Google Scholar 

  • Moody, T. W., Zia, F., Dravi, M., Brenneman, D. E., Fridkin, M., Davidson, A., and Gozes, I. (1993) A vasoactive intestinal peptide antagonist inhibits non-small cell cancer growth.Proc. Natl. Acad. Sci. USA 90, 4345–4349.

    Article  PubMed  CAS  Google Scholar 

  • Morris R. G. M., Anderson E., Lynch G. S., and Baudry M. (1986) Selective impairment of learning and blockade of long-term potentiation by anN-methyl-d-aspartate receptor antagonist, AP5.Nature 319, 774–776.

    Article  PubMed  CAS  Google Scholar 

  • Morris R. G. M., Garrud P., Rawlins J. N. P., and O’Keefe J. (1982) Place navigation impaired in rats with hippocampal lesions.Nature 297, 681–683.

    Article  PubMed  CAS  Google Scholar 

  • Nakamura T., Mahon K. A., Miskin R., Dey A., Kuwabara T., and Westphal H. (1989) Differentiation and oncogenesis: phenotypically distinct lens tumors in transgenic mice.New Biol. 1, 193–204.

    PubMed  CAS  Google Scholar 

  • Ottesen B., Wagener G., Virag R., and Fahrenkrug J. (1984) Penile erection: possible role for vasoactive intestinal polypeptide.Br. Med. J. 288, 9–11.

    CAS  Google Scholar 

  • Rosselin G., Anteunis A., Astesano A., Boissard C., Gali P., Hejblum G., and Marie J. C. (1988) Regulation of vasoactive intestinal peptide receptor.Ann. NY Acad. Sci. (Said S. I. and Mutt, V., eds.),527, 220–237.

    Article  PubMed  CAS  Google Scholar 

  • Said S. I. and Mutt V. (1970) Polypeptide with broad biological activity: isolation from small intestine.Science 169, 1217–1218.

    Article  PubMed  CAS  Google Scholar 

  • Southern E. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis.J. Mol. Biol. 98, 503–517.

    Article  PubMed  CAS  Google Scholar 

  • Sweeney J. E., Hohmann C. F., Moran T. H., and Coyle J. T. (1988) A long acting cholinesterase inhibitor reverse spatial memory deficits in mice.Pharmacol. Biochem. Behav. 31, 141–147.

    Article  PubMed  CAS  Google Scholar 

  • Tybulewicz V. L. J., Tremblay M. L., Lamarca M. E., Willemsen R., Stubblefield B. K., Winfield S., Zablocka B., Sidransky E., Martin B. M., Huang S. P., Mintzer K. A., Westphal H., Mulligan R. C., and Ginns E. I. (1992) Animal model of Gaucher’s diseae from targeted disruption of the mouse glucocerebrosidase gene.Nature 357, 407–410.

    Article  PubMed  CAS  Google Scholar 

  • Upchurch M. and Wehner J. M. (1988) Differences between inbred strains of mice in Morris Water Maze Performance.Behav. Genet. 18, 55–68.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gozes, I., Glowa, J., Brenneman, D.E. et al. Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene. J Mol Neurosci 4, 185–193 (1993). https://doi.org/10.1007/BF02782501

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02782501

Index Entries

Navigation